chr21-45491268-GC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_001379500.1(COL18A1):βc.2118delβ(p.Gly707AspfsTer17) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000621 in 1,611,236 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000026 ( 1 hom., cov: 32)
Exomes π: 0.0000041 ( 0 hom. )
Consequence
COL18A1
NM_001379500.1 frameshift
NM_001379500.1 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.80
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 21-45491268-GC-G is Pathogenic according to our data. Variant chr21-45491268-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 1416901.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr21-45491268-GC-G is described in Lovd as [Pathogenic]. Variant chr21-45491268-GC-G is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL18A1 | NM_001379500.1 | c.2118del | p.Gly707AspfsTer17 | frameshift_variant | 22/42 | ENST00000651438.1 | NP_001366429.1 | |
COL18A1 | NM_130444.3 | c.3363del | p.Gly1122AspfsTer17 | frameshift_variant | 21/41 | NP_569711.2 | ||
COL18A1 | NM_030582.4 | c.2658del | p.Gly887AspfsTer17 | frameshift_variant | 21/41 | NP_085059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL18A1 | ENST00000651438.1 | c.2118del | p.Gly707AspfsTer17 | frameshift_variant | 22/42 | NM_001379500.1 | ENSP00000498485 | |||
COL18A1 | ENST00000355480.10 | c.2658del | p.Gly887AspfsTer17 | frameshift_variant | 21/41 | 1 | ENSP00000347665 | |||
COL18A1 | ENST00000359759.8 | c.3363del | p.Gly1122AspfsTer17 | frameshift_variant | 21/41 | 5 | ENSP00000352798 | P1 | ||
COL18A1 | ENST00000342220.9 | c.159del | p.Gly54AspfsTer17 | frameshift_variant | 3/23 | 2 | ENSP00000339118 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152042Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152042
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459194Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 725964
GnomAD4 exome
AF:
AC:
6
AN:
1459194
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
725964
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152042Hom.: 1 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74244
GnomAD4 genome
AF:
AC:
4
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74244
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1416901). This variant has not been reported in the literature in individuals affected with COL18A1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gly707Aspfs*17) in the COL18A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL18A1 are known to be pathogenic (PMID: 12415512, 25456301). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at